Published on
August 21, 2024
- 11:00 GMT
Novaestiq’s Partner Croma-Pharma Announces Submission to the U.S. Food and Drug Administration for saypha® MagIQ™
1st submission in the United States for saypha® line of dermal fillers represents a key Novaestiq milestone SOUTHLAKE, TX, UNITED STATES, August 21, 2024 /EINPresswire.com/ -- Novaestiq Corp., a growth-oriented aesthetic company that focuses on …
Distribution channels:
Banking, Finance & Investment Industry, Beauty & Hair Care
...
